Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Patients who use oral formulations consistently show no meaningful change in IGF-1 levels after weeks or months of use
The primary endpoint will be bodyweight change (week 80 and 104), change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in the OA subset, and change in Apnoea-Hypopnea Index (AHI) in the OSA subset
PMID 28032133
For me, this has felt like giving my metabolism a soft place to land while my hormones do their midlife rollercoaster dance
Views expressed in Employer Coverage are purely my own.
Resistance training becomes non-negotiable
US$ 25.45
US$ 27.44
US$ 28.11
